Compagnie Lombard Odier SCmA’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$120K | – | 690 |
|
|
2021
Q2 | $120K | Sell |
10,000
-848,429
| -99% | -$10.2M | ﹤0.01% | 391 |
|
|
2021
Q1 | $10.8M | Buy |
858,429
+848,429
| +8,484% | +$10.6M | 0.24% | 78 |
|
|
2020
Q4 | $156K | Hold |
10,000
| – | – | ﹤0.01% | 345 |
|
|
2020
Q3 | $94K | Hold |
10,000
| – | – | ﹤0.01% | 326 |
|
|
2020
Q2 | $90K | Hold |
10,000
| – | – | ﹤0.01% | 325 |
|
|
2020
Q1 | $64K | Hold |
10,000
| – | – | ﹤0.01% | 333 |
|
|
2019
Q4 | $84K | Hold |
10,000
| – | – | ﹤0.01% | 322 |
|
|
2019
Q3 | $91K | Hold |
10,000
| – | – | ﹤0.01% | 312 |
|
|
2019
Q2 | $108K | Hold |
10,000
| – | – | ﹤0.01% | 292 |
|
|
2019
Q1 | $95K | Hold |
10,000
| – | – | ﹤0.01% | 348 |
|
|
2018
Q4 | $115K | Hold |
10,000
| – | – | ﹤0.01% | 312 |
|
|
2018
Q3 | $169K | Hold |
10,000
| – | – | 0.01% | 305 |
|
|
2018
Q2 | $142K | Buy |
+10,000
| New | +$142K | 0.01% | 320 |
|